Average Co-Inventor Count = 4.35
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (14 from 3,681 patents)
14 patents:
1. 7329668 - Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same
2. 7176214 - Imidazo-fused oxazolo[4,5-β]pyridine and imidazo-fused thiazolo[4,5-β]pyridine based tricyclic compounds and pharmaceutical compositions comprising same
3. 7071333 - Triazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same
4. 6960585 - Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same
5. 6869956 - Methods of treating inflammatory and immune diseases using inhibitors of IκB kinase (IKK)
6. 6825233 - Compounds having retinoid-like activity
7. 6350892 - Trifluoromethyl ketone analogs as selective cPLA2 inhibitors
8. 6331570 - Active enantiomer of RAR&ggr;-specific agonist
9. 6319948 - Retinoid antagonists and uses thereof
10. 6255496 - Trifluoromethyl ketone analogs as selective cPLA2 inhibitors
11. 6008251 - Retinoid-like compounds
12. 5945561 - Retinoid-like compounds
13. 5760084 - RAR.gamma.-specific retinobenzoic acid derivatives
14. 5624957 - Rary-specific retinobenzoic acid derivatives